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Abstract  
Background: Phlebitis is one of the common complications of intravenous therapy, with incidence rate ranging from 
3.2% to 71.25%. This study aimed to determine the incidence and associated factors of phlebitis, related to the inser-
tion of peripheral intravenous cannula, among pediatric patients at Hiwot Fana Specialized University Hospital, East-
ern Ethiopia.    
Methods: Institution-based prospective observational study was employed in 380 pediatric patients admitted to the 
pediatric and neonatal intensive care units of Hiwot Fana Specialized University Hospital from March to September, 
2017. Data were collected by using a structured observational checklist (Jackson’s Visual infusion phlebitis; FLAC; 
CONSOL ability and face’s pain rating scales). Patients were followed from the time of admission until discharge 
from the hospital or discontinuation of intravenous cannula. Data were analyzed using Statistical Package for the 
Social Sciences Version 20. Logistic regression analyses were performed and a P-value less 0.05 was considered as 
statistically significant.  
Results: The incidence of phlebitis was 33.7% (95% CI: 29.1, 38.6). Joint involvement for peripheral intravenous 
administration (AOR=2.07; 95% CI: 1.18, 3.66), indwelling time of 48-72 hours (AOR=2.22; 95% CI: 1.098, 4.485), 
pain during and after intravenous cannula insertion (AOR=1.32; 95% CI: 1.20, 2.50), and need of extra peripheral 
intravenous cannula insertion (AOR=3.93; 95% CI: 2.35, 6.58) were the factors significantly associated with phlebitis. 
Conclusion: The incidence of phlebitis was high. Its associated factors were joint involvement, indwelling time, pain 
during intravenous cannula insertion, and need for extra peripheral intravenous cannula. Therefore, nurses and other 
health care providers need to follow the standard protocol of the indwelling time of the catheter and exclude joint 
involvement. Regular assessment for early identification of symptoms and management of pain are also crucial.  
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Introduction  
Peripheral Intravenous Cannula (PIVC) insertion is 
the most commonly carried out invasive procedure in 
health institutions. It is estimated that more than 80% 
of hospitalized patients are subjected to PIVC with the 
cannula remaining in place for a considerable time 
(Foster et al., 2002; Williams, 2009). Venous cannulation 
provides relatively easy and comfortable access for in-
travenous (IV) therapy such as drugs, solutions and 
blood products, and to monitor the hemodynamic sta-
tus for hospitalized neonates and children. Despite its 
importance in sophisticated modern medical practice, 
the veins of the children are  so fragile  that the inser-
tion of IV cannula is very difficult (Kaur et al., 2011; 
Bitencourt et al., 2018). 
Phlebitis is characterized by pain, erythema, heat, 
edema, induration, palpable venous cord, and purulent 
exudates. It is one of the common complications of IV 
therapy. Among hospitalized patients, 3.2% to 71.25% 
of patients receiving IV therapy develop phlebitis  
(Nassaji-Zavareh and Ghorbani, 2007; Uslusoy and 
Mete, 2008; Nagpal et al., 2015; Waitt et al., 2004; 
Williams, 2009; Salgueiro-Oliveira et al., 2012; 
Serane and Kothendaraman, 2016; Karadeniz et al., 
2003; Parul, N. et al., 2015; Bitencourt et al., 2018).
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The commonest factors associated with phlebitis are 
improper insertion, longer indwelling time, site of in-
sertion, extra insertion, administration of highly vis-
cous irritants such as drugs, a poor standard of infec-
tion control which allowing entry of infectious agents, 
type and frequency of intravenous medications, and 
intermittent intravenous infusion (Ben-Abdelaziz et 
al., 2017; Dougherty and Lister, 2015; Foster et al., 
2002; Jacinto et al., 2014; Salgueiro-Oliveira et al., 
2012). The complications associated with phlebitis can 
have even fatal consequences for patients (Reis et al., 
2009). These include infection, thrombosis, and recur-
rent superficial thrombophlebitis. Septic thrombophle-
bitis is  rare but it is one of the most serious complica-
tions of phlebitis (Higginson and Parry, 2011). Be-
sides, complications arising from phlebitis can have 
long-term effects on patient care, satisfaction, length 
of hospital stay, and increase personal and financial 
cost to patients (Muchamad and Savitri, 2018).  
Nurses are at the forefront in providing IV therapy, and 
their knowledge and skill can minimize infusion-re-
lated complications. They can significantly influence 
the quality of care provided by adopting the principles 
associated with the safe management and care of pa-
tients who have these device in situ (Li and Qin, 2016). 
Phlebitis is avoidable if the nurses adhere to simple 
hygiene and safety principles at every point of contact 
they made with each patient (Ademola and Tolulope, 
2015; Salgueiro-Oliveira et al., 2012; Salma et al., 
2019).  
In developing countries, due to  scarcity of resources, 
educated manpower, and economic problem, the inci-
dence of PIVC complications including phlebitis is  
high (Cornely et al., 2002). To the best of our knowledge 
and extensive literature search, there is a little evi-
dence in Ethiopia and in the study area in particular. 
Therefore, this study aimed to determine the incidence 
of phlebitis and its associated factors among admitted 
neonates and children receiving PIVC at Hiwot Fana 
Specialized University Hospital (HFSUH), Harar, 
Eastern Ethiopia.   
Materials and methods  
Study setting, design and period 
The Harari Regional State is located 525 km east of 
Addis Ababa, capital of Ethiopia. The region has five 
hospitals (two public hospitals, one police hospital, 
and two private hospitals). Hiwot Fana Specialized 
Referral University Hospital (HFSUH) is one of the 
oldest public hospitals in Harar, the capital of the re-
gion. It provides service to people living in the eastern 
part of Ethiopia. It is a specialized teaching hospital 
and center for numerous medical and health science 
students. The hospital has six wards and six intensive 
care units. A prospective observational study was con-
ducted in the pediatric ward and neonatal intensive 
care units for consecutive six months, from March to 
September, 2017.  
Study participants, sample size, and sampling tech-
niques 
Neonates and children admitted to the pediatric ward 
and neonatal intensive care unit (NICU) with a PIVCs 
for the administration of intravenous therapy were in-
cluded. The minimum sample size was determined by 
using a single population proportion formula consid-
ering the following assumptions: the incidence of 
phlebitis (50%) (Uslusoy and Mete, 2008), the margin 
of error (5%), and 95% confidence interval. Hence, the 
calculated sample size was 422, after adding a 10% 
non-response rate.  
The past six-month admission record was analyzed 
and a total of 709 children and 178 neonates, received 
IV therapy, were admitted to HFUSH. The final sam-
ple size was proportionally allocated to the pediatric 
ward and NICU. A total of 337 children and 85 neo-
nates with IV cannula were sampled using a system-
atic random sampling technique. 
Data collection procedure 
Data were collected by five BSc Nurses working in the 
pediatric ward and NICU using standard tools and a 
structured observation checklist which was developed 
through literature review. Sociodemographic variables 
(child’s age, birth weight, gender), and clinical char-
acteristics (the diagnosis, body mass index (BMI) for 
age) were extracted from the clinical records of the pa-
tients. Jackson's Visual Infusion Phlebitis Score (Jack-
son, 1998) and Neonatal Infant Pain Scale (Snipstad et 
al., 2017) assessment tool were used (Hudson-Barr et 
al., 2002). The face, legs, activity, cry, controllability  
(FLACC) pain scale was used for children aged 2 
months to 1 year (Manworren and Hynan, 2003), and 
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faces pain scale for children aged  1year to 8 years, and 
numerical rating pain scale was also adopted for par-
ticipants aged 8-18 years (Hicks et al., 2001).   
Grade of phlebitis assessed using Jackson’s Visual in-
fusion phlebitis scale. Grade 0 had none of the typical 
symptoms of phlebitis such as pain, rash, and edema. 
Grade 1 described the early symptoms of phlebitis, 
such as slight pain at the site of IV cannula or redness 
near to IV site. Grade 2 phlebitis referred to mid-level 
disease: two of the following pain, erythema, and 
swelling, Grade 3 phlebitis is advanced phlebitis pain 
along the paths of the cannula, erythema, and indura-
tion. Grade in along the paths of the cannula, erythema 
induration, and palpable venous cord. Finally, grade 5 
phlebitis described advanced thrombophlebitis. This 
grade included grade 4 symptoms as well as pyrexia 
(Nagpal et al., 2015). 
Data related to the type of fluid, drug, infusion, num-
ber of injections per day, rate of IV infusion, the total 
amount of fluid per 24 hours, size of cannula, site of 
the cannula, joint involved, IV cannula indwelling 
time, number of trial mental status, nutritional status, 
type of glove used, and handwashing practice were 
collected through observation.    
Enrollment and follow-up 
Recruitment of study participants took place at the pe-
diatric ward and NICU triage immediately after admis-
sion. Primarily, data collectors invited the parents or 
guardians to participate in the study on behalf of their 
neonates and children. Those who accepted the invita-
tion were asked for their consent and assent for ado-
lescents. Then identification code was given for rec-
ords of enrolled participants and follow up was carried 
out until they discharged from the hospital or the in-
travenous cannula discontinued. During the follow-up, 
phlebitis and pain assessment scales were used. 
Quality control  
The observational checklist was pre-tested on 10% of 
the total sample size in Dilchora Hospital, Dire Dawa, 
and validated by the research team. Following the pre-
test, the necessary amendment was made accordingly. 
Three days of training on the objective of the study and 
the importance of data quality was given for the data 
collectors who were selected from respective ward and 
unit. The assessment of the sign of phlebitis, grades of 
phlebitis pain and other related complications for 
about a maximum duration of stay of a child using 
adapted standard guideline (Nagpal et al., 2015). The 
principal investigators monitored the entire data col-
lection process.  
Data processing and analysis 
Data were checked, coded and entered into EpiData 
software Version 3.2 and exported into SPSS Version 
21 for analysis. The descriptive analysis was con-
ducted to describe frequency distribution and propor-
tion. Tables and graphs were used to present the results 
of the analyzed data. The outcome variable was di-
chotomized as having and not having phlebitis (Yes/ 
No) and graded based on the phlebitis scale. Birth 
weight was categorized as normal birth weight (2.5- 4 
kg), low birth weight (1.5-2.5), and very low birth 
weight (<1.5kg) (UNICEF, 2004),  and nutritional sta-
tus was  classified as undernutrition (SD score and <-
2 BMI < 18.5 ) and normal nutritional status (SD score 
and 2 to -2 and  BMI 18.5–24.9) (WHO, 2010). Lo-
gistic regression analysis was used to assess the factors 
associated with the incidence of phlebitis. Those vari-
ables with a p-value of less than 0.2 in the bivariable 
analysis were included in the multivariate analysis. In 
multivariable analysis, the variables with p< 0.05 at 95 
% confidence interval were considered as a statistical 
significant. 
Operational definition 
Pain level classification 
Neonatal infant pain scale has a total pain score range 
from 0-7. Accordingly, pain level classification, 0-2 = 
mild to no pain; 3-4 = mild to moderate pain and >4 = 
severe pain (Snipstad et al., 2017).  
FLACC pain scale has a total pain score range from 0-
10. Accordingly, pain level classification, 0 = Relaxed 
and comfortable; 1-3=Mild discomfort; 4-6 = Moder-
ate pain and 7-10 = Severe discomfort/pain (Manwor-
ren and Hynan, 2003). 
Mental status classification:  
Conscious: Is the state or quality of awareness, or, of 
being aware of an external object or something within 
oneself (Letta, S.2016) 
Confusion: Disorientation and impaired thinking and 
responses to stimuli (Letta, S.2016) 
Irritability: increased proneness to anger and showing 
no interest in anything (Letta, S.2016) 
Lethargic: alternatively, sleepiness or drowsiness  
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Comatose: Inability to be aroused and no response to 
stimuli (Letta, S.2016) 
Ethical consideration  
Ethical approval for the study was secured from the 
Institutional Research Ethics Review Committee 
(IRERC) of the College of Health and Medical Sci-
ences, Haramaya University. A letter of permission 
was submitted to the hospital officers before the com-
mencement of data collection. All the study partici-
pants’ families and caregivers were informed about the 
purpose of the study and participation was fully vol-
untary. They were also informed about the right to re-
fuse and withdraw from the study at any time. The 
written consent/assent was also obtained from the 
study subjects and family/caregivers. Confidentiality 
was ensured through employing anonymity. Ethical 
conduct was maintained during data collection and 
throughout the research process. The staff has pro-
vided information to parent/guardian, appropriate 
strategy for preventing phlebitis and managing the 
identified symptoms of inflammation. 
 
Results  
Socio-demographic characteristics of study partic-
ipants 
A total of 422 study participants admitted to the NICU 
and pediatrics ward of HFSUH were included in this 
study; however, 42 participants lost from follow-up. 
Therefore, 380 participants were included in the anal-
ysis. More than three-fourth of the participants were 
admitted to the pediatric ward. Many of the study sub-
jects were male (59.7%). The mean and the standard 
deviation (SD) of the age of the neonates were four 
days (±1day) whereas the mean and the SD of the age 
of the children were 37 months (±13day). Over two-
third of the participants had normal weight whereas 
64.4% were in undernutrition (Table 1). 
Clinical related characteristics of study partici-
pants 
One hundred forty-eight (38.9%) of the admitted neo-
nates and children had more than one illness and 148 
(29.9%) had a co-morbid illness of respiratory system 
disorders and 57 (28.9%) neonates were diagnosed for 
sepsis. More than half (237 (62.4%)) of them were 
conscious (Table 2). 
 
Table 1: Socio-demographic characteristics of neonates and children admitted to the NICU and Pediatric ward of 
Hiwot Fana Specialized University Hospital, 2016. 
Variables Frequency Percentage (%) 
Unit   
Pediatric Ward 304 80.0 
NICU 76 20.0 
Sex (N=380)   
Male 227 59.7 
Female 153 40.3 
Age of Neonate (n=76)   
1-7 days 61 80.0 
>7 days 15 20.0 
Age of Child (n=304)   
1-6 months 72 24.0 
7-12 months 73 24.0 
13-24 months 54 18.0 
25 months & above 105 34.0 
Birth weight of Neonate (n=76)   
Normal 52 68.4 
Low birth Weight  18 23.6 
Very low birth weight 6 8.0 
Nutritional status (Child) (n=304)   
Normal 109 35.6 
Under nutrition 195 64.4 
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Table 2: Clinical related characteristics of neonates and children admitted to the NICU and pediatric ward of Hiwot 
Fana Specialized University Hospital, 2016. 
Variables Frequency  Percentage (%) 
Reason for admission of children (n=495)   
RS Disorders 148 29.9 
GIS Disorders 115 23.2 
Neurological Disorders 53 10.7 
CVS Disorders 40 8.1 
GUS Disorders 27 5.5 
Acute Febrile Illness 50 10.1 
Others* 62 12.5 
Reason for admission of neonates (n=197)   
Sepsis 57 28.9 
Anemia 54 27.4 
Hypothermia 34 17.3 
LBW and VLBW 24 12.2 
Preterm 19 9.6 
Congenital Malformations 9 4.6 
Mental Status   
Conscious 237 62.4 
Confused 22 5.8 
Irritable 60 15.8 
Lethargic 48 12.8 
Comatose 13 3.4 
NB: LBW: Low birth weight, VLBW: Very Low Birth Weight, RS: Respiratory system, GIS: Gastro-Intestinal System, GUS: Genito 
Urinary System, CVS: Cardio-Vascular System. 
* Others include: skin infection, human immunodeficiency virus (HIV) and diabetes mellitus (DM)  
Cannulation related characteristics 
In this study, 346 (91.1%) of the study participants 
used 24 gauges of cannula size. Of the two hundred 
twenty-eight (60%) of the IV cannulas inserted into 
the veins of dorsal hands, 209 (55%) had parallel cal-
culations in both hands. More than half insertion sites 
did not involve joint areas (57.9%) and the majority of 
the cannulas placed into the vein of the first trial of 
insertion (58.4%) (Table 3). 
Trends of peripheral intravenous cannulation 
A total of 76 neonates and 304 pediatric patients had 
received at least one cannula. More than half of pedi-
atrics (53.6%) received the second cannulas. However, 
successive cannulation continued in decreasing trend 
from the second cannula to the fifth cannula (Figure 
1). 
Applied infection prevention strategies and medi-
cation-related characteristics 
Almost all the nurses (374 (98.9%)) did not maintain 
handwashing before cannulation. Three hundred fifty 
eight (90%) of the cannulation was carried out by don-
ning disposable gloves. Most of the neonates and the 
children received dual antibiotics (91.8%). The pre-
dominant means of infusion or administration of med-
ications (211 (55.5%)) were carried out via dry can-
nula. More than three-fourth of the children and the 
neonates (293 (77.1%)) received IV medication one to 
two times a day (Table 4). 
 
 
 
5
Tefera et al.                                             East African Journal of Health and Biomedical Sciences, Volume 4 (1): 1-12 
 
 
Table 3: Cannulation related characteristics of neonates and children admitted to the pediatric ward and NICU of 
Hiwot Fana Specialized Hospital, 2016. 
Variables Frequency Percentage 
Size of cannula   
24 gauge 346 91.1 
22 gauge 34 8.9 
Site of IV cannula insertion   
Dorsal of hands 231 60.8 
Antecubital vein 99 26.1 
Scalp vein 21 5.5 
Others (legs and foot dorsal)  29 7.6 
Concurrent insertion of the cannula   
Yes 209 55 
No 171 45 
Joint involvement   
Yes 160 42.1 
No 220 57.9 
Number of trials for insertion    
One time 222 58.4 
Two to three times 143 37.6 
Four to six times 15 3.9 
 
 
Figure 1: Trends of the cannula insertion among neonates and children admitted to the pediatric ward and NICU of 
Hiwot Fana Specialized University Hospital, 2016. 
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Table 4: Applied infection prevention strategies and medication-related characteristics among neonates and children 
admitted to the pediatric ward and NICU of Hiwot Fana Specialized Hospital, 2016. 
Variables Frequency Percentage 
Hand washing before the procedure   
          Yes 4 1.1 
           No 374 98.9 
Types of glove used   
           Disposable 358 94.2 
           Surgical 22 5.8 
IV Medications’ administered   
           Dual antibiotics 349 91.8 
           Other drugs* 31 8.2 
Mode of infusion/administration   
           Dry cannula 211 55.5 
           Continuous 90 23.7 
           Intermittent 79 20.8 
Number of injections per day   
           One to two times 293 77.1 
           Three to four times 84 22.1 
            More than four times 3 0.8 
*Other drugs: diuretic drugs, anti-emetic drugs, anticonvulsant drugs, and anti-pain 
Incidence of phlebitis and related characteristics 
The incidence of phlebitis in the present study was 
33.7% (95% CI: 29.1%, 38.6%). Forty-eight (37.5%) 
of the study participants developed phlebitis in in-
dwelling time at 72-96 hrs. More than half of the 73 
(57%) developed phlebitis in the first cannula inser-
tion. Near to one-third of the study participants, 111 
(29.2%), experienced pain at various degrees and just 
about half experienced moderate pain (Table 5).  
Factors associated with the incidence of phlebitis 
In the bivariate analysis, having pain, cannula size of 
22 gauge, joint involvement, need extra insertion, and 
indwelling time were associated with the outcome var-
iable. The following variables showed a statistically sig-
nificant association in multivariable analysis. Those pa-
tients who needed extra cannula insertion were four 
times (AOR=3.93; 95% CI: 2.35, 6.58) more likely to 
develop phlebitis. Similarly, the study subjects whose 
cannulation involved the joints were 2 times 
(AOR=2.07: 95% CI: 1.18, 3.66) more likely to de-
velop phlebitis compared to those without cannula 
over their joints. Those participants with indwelling 
time of 48-72 hours (AOR= 2.22: 95% CI: 1.10, 4.49) 
and 72-96 hours (AOR=1.51; 95% CI: 1.30, 3.99) 
were more likely develop phlebitis than those with in-
dwelling time of >120hrs.The incidence of phlebitis 
was 1.32 times (AOR=1.32; 95% CI: 1.20, 2.50) more 
likely in those who had pain than those had no pain 
(Table 6). 
Discussion 
The incidence of phlebitis in the present study was 
33.7 %, more than half of phlebitis were grade two and 
above and developed it on the first cannula. The need 
for extra cannula, insertion involved joints, indwelling 
time and having pain were factors identified to be as-
sociated with the incidence of phlebitis.  
Literature witnessed that phlebitis is a common and 
painful complication of peripheral intravenous cannu-
lation. The incidence of phlebitis in this study is con-
sistent with the one found by a study conducted in Bra-
zil (34% among children aged from 0 to 2 years) 
(Bitencourt1 et al., 2018). However, it is lower than 
the findings from Turkey (67.24%) and India 
(71.25%) (Uslusoy and Mete, 2008; Nagpal et al., 
2015). But, it is greater than 5% of the accepted level 
of incidence by the clinical guideline (O'grady et al., 
2011) and a study conducted in Austria (1.5%), Portu-
gal (11.09%), Curitiba (Brazil) (17%) and Iran (26%) 
(Nassaji-Zavareh and Ghorbani, 2007; Salgueiro-
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Oliveira et al., 2012; Danski et al., 2016; Malyon et 
al., 2014). This discrepancy might be due to the differ-
ence in sample size, study population and infection 
prevention practice. A strict application of infection 
prevention strategies such as hand hygiene procedures, 
use of surgical gloves and disinfectants showed a rela-
tionship with a low incidence of phlebitis (O'grady et 
al., 2011). However, in the current study, almost all 
cannulas were inserted without hand hygiene and us-
ing disposable gloves.
Table 5: phlebitis and related characteristics among Neonates and children admitted to the pediatric ward and NICU 
of Hiwot Fana Specialized Hospital, 2016. 
Variables Frequency Percentage 
Phlebitis   
Yes 128 33.7 
No 252 66.3 
Time between indwelling cannula and phlebitis development   
<48 hrs. 6 4.6 
48-72 hrs.  28 21.8 
72-96 hrs.  48 37.5 
96-120 hrs. 34 26.6 
>120 hrs. 12 9.4 
Incidence of phlebitis per cannula (n=128)   
Cannula 1 73 57 
Cannula 2 41 32 
Cannula 3 14 11 
Degree of phlebitis   
Grade I 56 43.8 
Grade II 51 39.8 
Grade III 16 12.5 
Grade IV 5 3.9 
Pain   
Yes 111 29.2 
No                                             269 70.8 
Degree of pain (n=111)   
Mild  55 49.9 
Moderate 56 50.1 
 
The present study demonstrated that the indwelling 
time of 48-72 hours and 72-96 hours had association 
with the incidence of phlebitis. This agrees with the 
ones reported from Italy and India developed phlebitis 
after 48 hours of indwelling (Nagpal et al., 2015, 
Bagnasco et al., 2011) and with another finding of a 
study conducted in India, which indicates that there is 
a higher risk of phlebitis if the IV cannula remains in 
veins for 72-96 hours (Saini et al, 2011). In addition, 
the medication load had a great impact on the occur-
rences of phlebitis (Nagpal et al., 2015).  
This study presented that phlebitis was more common 
in those study participants with joint involvement site. 
This is similar to a finding by a study conducted in In-
dia (Saini et al., 2011). This might be because of there 
is  the underlying movement of the joints, causing the 
cannula to be in direct contact with the intimae of the 
vein, damaging it, and resulting in phlebitis (Furtado, 
2011). This study also identified the presence of pain 
as a predictor of phlebitis. This is in line with a study 
finding in Canada (Wagan, 2014; Boyce and Yee, 
2012).  
 Pain is one of the symptoms of phlebitis that could be 
presented at any insertion site with various degrees.  It 
could also be caused by extrusive tissue trauma, infil-
tration infused fluid, medication into interstitial space 
8
Tefera et al.                                                   Incidence and Its Associated Factors of Phlebitis in Intravenous Cannula 
 
 
and joint involvement (Ying-yi, 2012; Uslusoy and 
Mete, 2008). 
This study also revealed that the need for extra inser-
tion of the cannula had an association with phlebitis. 
This is contrary to the finding by a study conducted in 
Australia which indicates the need for extra insertion 
of the cannula was not associated with phlebitis (Wal-
lis et al., 2014). The discrepancy might be due to the hos-
pital setting, infection prevention policy, the experi-
ence of the health professionals and subsequent care 
given for the patient after insertion of the cannula. 
The strength of this study is that it was an observa-
tional study with a follow-up. However, the study was 
conducted in one hospital and specific to certain age 
groups is its limitation. Hence, this study might not be 
generalizable to all ages. Moreover, future research is 
required by considering a quite large sample size from 
diverse hospitals and age groups to get the full picture 
of phlebitis and associated factors. 
Table 6: Factors associated with phlebitis among neonates and children admitted to the NICU and Pediatric ward of 
Hiwot Fana Specialized Hospital, 2016. 
Variables            Phlebitis COR (95% CI) AOR (95% CI) 
Yes 
N (%) 
No 
N (%) 
Sex     
Male 81 (35.7) 146 (64.3) 0.79 (0.52, 1.24) 0.62 (0.46, 1.63) 
Female 47 (30.7) 106 (69.3) 1 1 
Cannula’s size     
22 Gauge 17 (50.0) 17 (50.0) 0.47 (0.23, 0.96)  0.16 (0.10, 1.53) 
24 Gauge 111 (32.1) 235 (67.9) 1 1 
site of vein punctured     
Scalp  6 (28.6) 6 (71.4) 2.03 (0.62,6.72) 1.04 (0.24, 1.41) 
Antecubital 24 (24.2) 75 (75.8) 2.54 (1.07,6.03) 2.07 (0.61, 7.11) 
Dorsum of hands 85 (36.8) 146 (63.2) 1.40 (0.64, 3.04) 1.92 (0.72, 5.15) 
Others (legs and foot) 13 (44.8) 16 (55.2) 1 1 
Extra insertion     
Yes 99 (77.30)    29 (22.7)  4.41 (2.72, 7.14)  3.93 (2.35, 6.58) * 
No 110 (43.6) 142 (56.3) 1  
Joint involvement     
Yes 72 (45) 88 (55) 2.39 (1.55, 3.70)  2.07 (1.18, 3.66) * 
No 56 (26) 164 (74) 1 1 
Indwelling time in hours     
<48  6 (9.7) 56 (90.3) 0.39 (0.13, 1.12) 2.59 (0. 89, 7.50) 
48-72 28 (57) 21 (43) 0.45 (0.22,0.91) 2.22 (1.10, 4.49) * 
72-96  48 (52.7) 43 (48.3) 1.855 (1.01, 3.39) 1.51 (1.30,3. 99) * 
96-120 34 (27.6) 89 (72.4) 0.79 (0.43, 1.47) 1.26 (0.68, 2.33) 
>120hr 12 (21.8) 43 (78.2) 1 1 
Pain in insertion of a cannula      
Yes 58 (52.3) 54 (47.7) 3.16 (1.99,5.011)  1.32 (1.20,2.50) * 
No 69 (25.7) 199 (74.3) 1 1 
      *Statistically significance with p<0.05 
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Conclusion  
In this study, there is a high incidence of phlebitis at 
the NICU and pediatrics ward of Hiwot Fana Special-
ized University hospital. It is more than stated as ac-
cepted in clinical guideline. More than half of phlebitis 
were grade two and above and occurred in the first 
cannula. Joint involvement for intravenous admin-
istration, indwelling time of 48-72 and 72-96 hours, 
the presence of pain during intravenous cannula inser-
tion, and need extra peripheral intravenous cannula in-
sertion were identified as predictors of phlebitis. 
Therefore, health professionals working at the NICU 
and pediatric ward of the hospital should strictly apply 
aseptic techniques during the insertion of the periph-
eral intravenous cannula, consider replacement of IV 
cannula every 48–96 hours, and exclude joints to min-
imize the risk of phlebitis. Strict cautions need to fol-
low by health professional to reduce pain associated 
with tissue trauma and to avoid extra insertion. Be-
sides, the nurses/health professional working  on the 
child care in the hospital need to timely assess the 
symptoms of phlebitis, manage accordingly and  mon-
itor it in order   to prevent further complications.  
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